Not Signed In - Critical Therapeutics Files Controlled Release Formulation Of Zileuton
Wed, 02 Aug 2006 06:00 AM EST
... SkyePharma PLC (Nasdaq: SKYE;LSE: SKP) announces that its partner Critical Therapeutics Inc ("CTI",Nasdaq: CRTX) has submitted a New Drug Application to the US Food & DrugAdministration for a controlled-release formulation of the oral anti-inflammatory drug zileuton for asthma in adults and children aged 12 yearsor older. [click link for full article] ...
Related Topics
- Critical Care
- Zileuton
- Pharmacology
- Pediatric Care
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Niacin Extended Release
- Lovastatin Extended Release
- Valproic Acid Delayed or Extended-Release or Sprinkle Capsule
- Bexarotene Oral
- Metformin Extended-Release
- Pseudoephedrine Extended Release
- Bupropion Extended-Release
- Chlorpromazine Extended-Release Capsules
- Myopathy
- Hepatitis B Vaccine
- Quinidine Extended-Release
- Isradipine Extended-Release Tablets
- Didanosine Delayed Release Capsule
- Metronidazole Extended Release
- Glipizide Extended-Release
email this page
print this page
bookmark this page
feedback on this page
